Brief: Indaptus Therapeutics Activates Emory Winship Cancer Institute As Trial Site In INDP-D101
13/03/2023 12:28
March 13 (Reuters) - Indaptus Therapeutics Inc INDP.O :
* INDAPTUS THERAPEUTICS ACTIVATES EMORY WINSHIP CANCER
INSTITUTE
AS TRIAL SITE IN INDP-D101, ITS ONGOING PHASE 1 OPEN LABEL
CLINICAL TRIAL OF DECOY20 IN PATIENTS WITH ADVANCED SOLID TUMORS
Source text for Eikon: ID:nGNX3nLSLN
Further company coverage: INDP.O
((Reuters.Briefs@thomsonreuters.com;))